MarketBeat
10 May 2026, 03:06 UTC · 21w ago
Ginkgo Bioworks Q1 Earnings Call Highlights
Verdict
Headline takes no side. We score DNA −0.20 across five claims — slightly bearish.
- Expected · DNA
−0.20slightly bearish
−1 bearish0bullish +1More negative than 65% of ticker scores this week
- Actual
Scored by the NIS engine · methodology.





